Lodestone Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.46M Sell
5,732
-249
-4% -$58K 0.51% 57
2026
Q1
$1.46M Sell
5,981
-3
-0.1% -$699 0.58% 54
2025
Q4
$1.24M Sell
5,984
-95
-2% -$18.8K 0.5% 59
2025
Q3
$1.13M Sell
6,079
-1
-0% -$171 0.51% 58
2025
Q2
$929K Sell
6,080
-337
-5% -$51.8K 0.45% 65
2025
Q1
$1.06M Buy
6,417
+163
+3% +$25.5K 0.57% 56
2024
Q4
$904K Sell
6,254
-349
-5% -$54.1K 0.45% 62
2024
Q3
$1.07M Sell
6,603
-672
-9% -$107K 0.54% 59
2024
Q2
$1.06M Sell
7,275
-1,667
-19% -$248K 0.56% 59
2024
Q1
$1.41M Buy
8,942
+7
+0.1% +$1.11K 0.74% 51
2023
Q4
$1.4M Sell
8,935
-261
-3% -$40K 0.81% 44
2023
Q3
$1.43M Sell
9,196
-1,029
-10% -$170K 1% 39
2023
Q2
$1.69M Sell
10,225
-67
-0.7% -$10.8K 1.16% 29
2023
Q1
$1.6M Buy
10,292
+287
+3% +$46.3K 1.23% 31
2022
Q4
$1.77M Buy
+10,005
New +$1.73M 1.43% 22

Other funds holding JNJ

Lodestone Wealth Management's JNJ Position: Q2 2026 in Review

Lodestone Wealth Management reduced its Johnson & Johnson (JNJ) stake by 4.2% in Q2 2026, selling an estimated $58K and leaving 5,732 shares worth $1.46M. The position accounts for 0.51% of the portfolio, ranked #57.

Lodestone Wealth Management first reported a position in JNJ in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.77M in Q4 2022. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Lodestone Wealth Management held 5,732 shares of Johnson & Johnson worth $1.46M as of Q2 2026.
  • Lodestone Wealth Management sold 249 Johnson & Johnson shares in Q2 2026, an estimated $58K.
  • Johnson & Johnson made up 0.51% of Lodestone Wealth Management's portfolio in Q2 2026, its #57 holding.
  • Lodestone Wealth Management first reported a position in Johnson & Johnson in Q4 2022 and has held it in 15 quarters since.
  • Lodestone Wealth Management's Johnson & Johnson position peaked at $1.77M in Q4 2022.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Lodestone Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.